1[1]Walsh PM,Physician' s Desk Referance(PDR)[M].57th edition.Montval,NJ:Thomson PDR,2003.1225-1226.
2[2]Navas Serrano VM,Cuevas Garcia MA,Vila Alvarez JA,et al.Prophylaxis and treatment of respiratory distress syndrome with different surfactants[J].An Esp Pediatr,2002,56(1):40-44.
3[3]Ainsworth SB,Beresford MW,Milligan DW,et al.Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates bom at 25～29 weeks' gestation:a randomised trial[J].Lancet,2000,355(9213):1387-1392.
4[4]Morley C.Pumactant and poractant alfa in respiratory distress syndrome[J].Lancet,2000,356(9231):765-768.
5金汉珍，实用新生儿学（第2版），1997年，350页
6吴瑞萍，诸福棠实用儿科学（第6版），1996年，449页
7宋国维，新生儿科杂志，1995年，1卷，57页
8Lal L,Kotecha S.Surfactant therapy.Journal of Neonatal Nursing.2000,2(6):Step by step geide.
9Wallace JL.Suctioning - a two-edged sword:Reducing the theory - practice gap.Journal of Neonatal Nursing.1998,6(4):12-17.
10Victor YH, Zekang Feng, Reginald CT,et al . Textbook of neonatal medicine : a Chinese perpective . Hong Kong : Hong Kong University Press , 1996. 255-263.
9Vallsi Soler A, Paaramo Andres S, Fernandez-Ruanova B, et al. Prenatal corticosteroid and early surfactant therapy in infants born at < or = 30 weeks gestation [ J ]. An Pediatr (Barc), 2004,61 ( 2 ) : 118 - 123.
